| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Bauerlein Alison | Chief Operating Officer | C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK | /s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein | 05 Feb 2026 | 0001596080 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGHT | Common Stock | Award | $0 | +127,512 | +21% | $0.000000 | 727,495 | 03 Feb 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $825,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. |
| F2 | Includes (i) 135,620 shares of Common Stock, and (ii) 591,875 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |